Publications
This section collects the most significant scientific contents of EGOI-PCOS members concerning the use of inositols alone or in association, both in basic research and for clinical application.
Also, the most relevant and updated literature on diagnosis and therapy of PCOS is gathered.
In particular, this collection includes the most recent original articles, clinical trials, reviews and meta-analyzes on the use of inositols especially in the gynecological, reproductive, metabolic, and endocrine fields.
Manuscripts inserted deal with important issues such as Polycystic Ovary Syndrome (PCOS), metabolic syndrome, insulin resistance, gestational diabetes with its complications, neurological defects for the unborn children linked to the nutritional deficiencies of mothers.
The Role of Inositol in Thyroid Physiology and in Subclinical Hypothyroidism Management
Authors: Salvatore Benvenga, Maurizio Nordio, Antonio Simone Laganà and Vittorio Unfer
Positive effect of a new supplementation of vitamin D 3 with myo-inositol, folic acid and melatonin on IVF outcomes: a prospective randomized and controlled pilot study
Authors: Maria Salomé Bezerra Espinola, Gabriele Bilotta, Cesare Aragona
A multicenter clinical study with myo-inositol and alpha-lactalbumin in Mexican and Italian PCOS patients
Authors: I. Hernandez Marin, O. Picconi, A. S. Laganà, L. Costabile, V. Unfer
Evaluation of Myo-inositol Effects upon Frozen-Thawed Bovine Sperm Quality
Authors: Verón, Gustavo Luis, Paladea, Rocío, Bello, Ricardo, Manjon, Ania Antonella1, Monti, Juan Ignacio and Vazquez-Levin, Mónica Hebe
Myoinositol plus α-lactalbumin supplementation, insulin resistance and birth outcomes in women with gestational diabetes mellitus: a randomized, controlled study
Authors: Rosario D’Anna, Francesco Corrado, Saverio Loddo, Giuseppe Gullo, Loretta Giunta & Antonino Di Benedetto
PCOS and Inositols: Controversial Results and Necessary Clarifications. Basic Differences Between D-Chiro and Myo-Inositol
Authors: Giovanni Monastra, Ivana Vucenik, Abdel Halim Harrath, Saleh H. Alwase, Zdravko A. Kamenov, Antonio Simone Laganà, Noemi Monti, Valeria Fedeli and Mariano Bizzarri
From Myo-inositol to D-chiro-inositol molecular pathways
Authors: A. K. Kiani, S. Paolacci, A. E. Calogero, R. Cannarella, G. C. Di Renzo, S. Gerli, C. Della Morte, G. M. Busetto, E. De Berardinis, F. Del Giudice, L. Stuppia, F. Facchinetti, S. Dinicola, M. Bertelli
Inositol treatment for psychological symptoms in Polycystic Ovary Syndrome women
Authors: T. Cantelmi, E. Lambiase, VR. Unfer, R. Gambioli, V. Unfer
EGOI joins the Alliance for Health Promotion
Since March 1st, 2021 EGOI has joined the Alliance for Health Promotion (A4HP), a non-governmental organization (NGO) affiliated with the World Health Organization (WHO).
The use of D-chiro-Inositol in clinical practice
Authors: R. Gambioli, G. Forte, C. Aragona, A. Bevilacqua, M. Bizzarri, V. Unfer